Constellation Pharmaceuticals and The Leukemia & Lymphoma Society Partner to Develop Novel BET Inhibitor for the Treatment of Hematologic Malignancies
9/20/2012 10:22:54 AM
More...
|
Constellation Pharmaceuticals Appoints Keith E. Dionne, Ph.D., as Chief Executive Officer
3/27/2012 6:52:54 AM
More...
|
Genentech (RHHBY) Pours $95 Million into Constellation Pharmaceuticals Epigenetic Drug Platform, Deal Includes M&A Terms
1/17/2012 6:55:55 AM
More...
|
Constellation Pharmaceuticals Raises $15 Million in Additional Funding
6/6/2011 6:34:59 AM
More...
|
Constellation Pharmaceuticals Expands Leadership Team with Drug Development Industry Veterans
2/1/2011 8:44:14 AM
More...
|
Constellation Pharmaceuticals Appoints Industry Veteran James E. Audia, Ph.D. as Chief Scientific Officer
1/4/2011 8:58:18 AM
More...
|
Constellation Pharmaceuticals Closes $22 Million in Series B Funding
6/2/2010 6:32:11 AM
More...
|
Constellation Pharmaceuticals Appoints Industry Veteran Garen Bohlin to Senior Management Group
1/20/2010 9:00:46 AM
More...
|
Constellation Pharmaceuticals Appoints Kerry K. Reinertsen, Ph.D. as Company's Chief Business Officer
1/7/2010 9:05:46 AM
More...
|
Constellation Pharmaceuticals Selected by AlwaysOn as an OnDC Top 100 Winner
10/8/2009 1:14:46 PM
More...
|
|